Blood Cancer Journal

Publisher:: Springer Nature
ISSN:: 2044-5385
Category:: ONCOLOGY
Impact factor:: 12.9

Feed status

2 parsed articles

Last update: Not fetched

Latest articles

Effectiveness of linvoseltamab versus real-world standard-of-care in triple-class-exposed relapsed/refractory multiple myeloma in the United States

2026-04-01

Shaji Kumar, Katja C. Weisel, Paul Spin, Nicolle Bonar, Muhaimen Siddiqui, Mostafa Shokoohi, Di Wang, Kevin Hou, Michael E. D. West, Christian Hampp, Jeannette Green, James Harnett, Olivier Humblet, Alexander Breskin, Wenzhen Ge, Jessica J. Jalbert, Rachel E. Sobel, Glenn S. Kroog, Karen Rodriguez Lorenc, Qiufei Ma, Sundar Jagannath

Blood Cancer Journal, Published online: 01 April 2026; doi:10.1038/s41408-026-01470-6 Effectiveness of linvoseltamab versus real-world standard-of-care in triple-class-exposed relapsed/refractory multiple myeloma in the United States

Management of hematological toxicities after BCMA-directed CAR-T cell therapy

2026-03-30

Joselle Cook, Supriya Gupta, Nadine Abdallah, Matthew Rees, Christopher Graham, Lay She Ng, Radhika Bansal, Andre De Menezes Silva Corraes, Kristina Helms, Rahma Warsame, David Dingli, Wilson Gonsalves, Taxiarchis Kourelis, Morie Gertz, Suzanne Hayman, Nelson Leung, Prashant Kapoor, Lisa Hwa, Amie Fonder, Miriam Hobbs, Leif Bergsagel, Udit Yadav, Erin Wiedmeier-Nutor, Saurabh Chhabra, Rafael Fonseca, Sikander Ailawadhi, Ricardo Parrondo, Shaji Kumar, Yi Lin

Blood Cancer Journal, Published online: 30 March 2026; doi:10.1038/s41408-026-01455-5 Management of hematological toxicities after BCMA-directed CAR-T cell therapy